| Tue 31 Mar 2009, 17:11 | | STXIND - Satrix Indi - Abridged Audited Results For The Year Ended |
|
JSE STXIND
STX2
STXIND - Satrix Indi - Abridged Audited Results For The Year Ended
31 December 2008
SATRIX INDI
A portfolio in the Satrix Collective Investment Scheme ("Satrix"), registered as
such in terms of the Collective Investment Schemes Control Act, 45 of 2002 (the
"Act")
JSE code: STXIND
ISIN CODE: ZAE000036364
ABRIDGED AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2008
INCOME STATEMENT
for the year ended 31 December 2008
2008 2007
R R
REVENUE
Dividend income 10 371 159 9 308 288
Fee income: Securities lending 558 896 713 476
Interest income 153 665 156 408
Withholding tax received 26 021 8 746
11 109 741 10 186 918
Fair value adjustments, net of transaction costs (1 260 662) (547 218)
EXPENSES
Management and administrative expenses (1 967 875) (1 972 428)
Income available for distribution 7 881 204 7 667 272
Distributions (8 307 577) (8 493 504)
Change in net assets attributable to investors (426 373) (826 232)
before tax
Taxation - -
Change in net assets attributable to investors (426 373) (826 232)
BALANCE SHEET
as at 31 December 2008
2008 2007
R R
ASSETS
Listed investments held at fair value through 470 341 10 407 174
profit or loss 8 519
Trade and other receivables 167 894 9 416 725
Cash and cash equivalents 1 078 649 751 144
Total assets 471 587 65 417 342
1 388
LIABILITIES
Net assets attributable to investors 470 462 68 407 722
1 465
Trade and other payables 1 124 970 9 619 923
Total liabilities 471 587 65 417 342
1 388
STATEMENT OF CHANGES IN NET ASSETS ATTRIBUTABLE TO INVESTORS
for the year ended 31 December 2008
Capital Income Total
attributable attributable
to investors to investors
R R R
Balance at 1 January 2007 780 557 271 1 374 178 781 931 449
Change in net assets - (826 232) (826 232)
attributable to investors
Revaluation of securities 89 888 163 - 89 888 163
Net liquidation of securities (463 270 915) - (463 270 915)
Balance at 31 December 2007 407 174 519 547 946 407 722 465
Change in net assets - (426 373) (426 373)
attributable to investors
Revaluation of securities (87 686 021) - (87 686 021)
Net creation of securities 150 852 610 - 150 852 610
Balance at 31 December 2008 470 341 108 121 573 470 462 681
CASH FLOW STATEMENT
for the year ended 31 December 2008
2008 2007
R R
Cash utilised by operations (2 112 876) (1 658 116)
Dividend income 10 678 097 9 764 816
Fee income: Securities lending 603 184 803 921
Interest income 153 291 153 201
9 321 696 9 063 822
Net cash (outflow)/inflow from investing (152 113 272) 462 909 632
activities
Net cash inflow/(outflow) from financing 143 119 081 (471 959 858)
activities
Net creation/(liquidation) of securities 150 852 610 (463 270 915)
Cash distributed to security holders (7 733 529) (8 688 943)
Net increase in cash and cash equivalents 327 505 13 596
Cash and cash equivalents at the beginning of 751 144 737 548
year
Cash and cash equivalents at the end of year 1 078 649 751 144
NOTES TO THE FINANCIAL STATEMENTS
For the year ended 31 December 2008
Basis of preparation
The financial statements are prepared on a historic cost
basis, except for financial instruments which are accounted
for as set out in note 1.1.
Statement of compliance
The financial statements are prepared in accordance with
International Financial Reporting Standards ("IFRS") issued
by the International Accounting Standards Board ("IASB"),
and in accordance with the requirements of the Standard
Exchange Traded Fund Trust Deed approved by the Financial
Services Board ("FSB") and the Collective Investment Schemes
Control Act No 45 of 2002 ("CISCA").
The financial statements incorporate the principal
accounting policies set out below, which are consistent with
those adopted in the previous financial year.
1.1 Financial instruments
Measurement
Financial instruments are recognised when, and only when,
the Portfolio becomes a party to the contractual provisions
of that particular instrument. Financial instruments are
initially measured at their fair value plus, in the case of
instruments not at fair value through profit and loss,
transaction costs that are directly attributable to the
acquisition or issue of the instruments. Subsequent to
initial recognition these instruments are measured as set
out below.
Investments
Listed investments are measured at fair value through profit
or loss. Fair value is determined with reference to quoted
market prices at the balance sheet date, as published in the
financial press at reporting date.
Trade and other receivables
Trade and other receivables are measured at amortised cost
using the effective interest rate method, less impairment
losses. Trade and other receivables are short term in nature
and are not discounted.
Cash and cash equivalents
Cash and cash equivalents are measured at amortised cost.
Financial liabilities
Financial liabilities, other than those held at fair value
through profit or loss, are measured at amortised cost.
Financial liabilities arising from the securities issued by
the Portfolio are measured at the fair value representing
the investor`s right to an interest in the Portfolio`s net
assets, i.e. the Net Asset Value ("NAV") of the Portfolio.
Changes in the fair value are included in net profit or loss
in the period in which the change arises and is designated
as at fair value through profit or loss.
1.1
Offset
Financial assets and financial liabilities are offset and
the net amount reported in the balance sheet when the
Portfolio has a legally enforceable right to set off the
recognised amounts, and intends either to settle on a net
basis, or to realise the asset and settle the liability
simultaneously.
Derecognition of financial instruments
The Portfolio derecognises financial assets when and only
when:
The contractual rights to the cash flows arising from the
financial assets have expired or have been forfeited by the
Portfolio; or
It transfers the financial assets including substantially
all the risks and rewards of ownership of the assets; or
It transfers the financial assets, neither retaining nor
transferring substantially all the risks and rewards of
ownership of the asset, but no longer retains control of the
assets.
A financial liability is derecognised when and only when the
liability is extinguished, i.e. when the obligation
specified in the contract is discharged, cancelled or has
expired.
On derecognition of a financial instrument in its entirety
(or part thereof), the difference between the carrying
amount and the sum of the consideration received (including
any new asset obtained less any new liability assumed) is
recognised in profit or loss.
1.2 Trade and other payables
Trade payables and other accounts payable are recognised
when the Portfolio becomes obligated to make future payments
resulting from the purchase of goods and services.
1.3 Revenue
Revenue comprises income from securities lending activities
and investment income.
1.4 Securities lending fee income
The fees earned for the administration of securities lending
activities are accounted for on an accrual basis in the
period in which the service is rendered. Assets subject to
securities lending are not derecognised.
1.5 Investment income
Interest income is recognised in the income statement, using
the effective rate method taking into account the expected
timing and amount of cash flows.
Dividends in the form of cash and manufactured dividends are
recognised when the right to receive the expected payment is
established.
Manufactured dividends received are recognised as income in
the income statement.
1.6 Cash and cash equivalents
Cash and cash equivalents comprise bank balances.
1.7 Taxation
Under the current system of taxation in South Africa, the
Portfolio is exempt from paying tax on income or capital
gains that are distributed to investors. Both income and
capital gains are taxed in the hands of the investor.
1.8 Securities lending
The Portfolio engages in securities lending activities for
up to 70% of the market value of assets under management
which is permitted by the Portfolio Trust Deed and approved
by the Trustee. Collateral is held by the lending desk of
the relevant financial institutions. For more detail,
1.9 Expenses
Expenses are recognised as incurred.
1.10 Impairment
Financial assets that are measured at amortised cost are
reviewed at each balance sheet date to determine whether
there is objective evidence of impairment. An impairment
loss is recognised in the income statement as the difference
between the asset`s carrying amount and the present value of
estimated future cash flows discounted at the financial
asset`s original effective interest rate.
If in subsequent period the amount of an impairment loss
recognised on a financial asset carried at amortised cost
decreases and the decrease can be linked objectively to an
event occurring after the write down, the write down is
reversed through the income statement.
1.11 Distributions
Distributions payable on redeemable securities are
recognised in the income statement as distributions.
1.12 Creations and redemptions
Investors can acquire Satrix securities by trading on the
JSE Limited. These purchases will be made at the current
market price of the securities plus a brokerage fee that is
negotiable with the broker and any additional transaction
costs applicable to such a trade.
The cash subscription price and the number of Satrix
securities to be issued to an investor for cash will be
determined by the amount which the investor invests (net of
transaction costs) and will be a function of the pro rata
cost to the Portfolio of acquiring the underlying basket of
securities.
Investors subscribing for Satrix INDI securities, by the
delivery of one or more full baskets of constituents
securities, are obligated to subscribe for securities in
blocks of 1 million Satrix securities.
Investors may sell securities by trading on the JSE Limited.
Security prices are determined by reference to the net
assets of the Portfolio divided by the number of securities
in issue. For unit pricing purposes, net assets are
determined using the last reported trade price for
securities. These prices may differ from the market price
quoted on the JSE Limited.
1.13 Redeemable securities
All redeemable securities issued by the scheme provide
investors with the right to require redemption for cash or
in specie at the value proportionate to investor`s share.
Such instruments give rise to a financial liability for the
net asset value of the redemption amount in the Portfolio`s
net assets at redemption date. In accordance with the
Portfolio`s Trust Deed and CISCA, the Portfolio is
contractually obliged to redeem securities at the net asset
value.
These securities have been designated as at fair value
through profit or loss as they eliminate an accounting
mismatch due to the underlying investments being classified
as fair value through profit or loss.
1.14 Distributions
In accordance with the Portfolio`s Trust Deed, the Portfolio
distributes its distributable income and any other amounts
determined by the Management Company, to security holders in
cash. The distributions are payable at the end of each
quarter and recognised in the income statement as
distributions.
1.15 Net assets attributable to security holders
Securities are redeemable at the security holder`s option
and are therefore classified as financial liabilities. The
securities may be sold back to the Portfolio at anytime. The
fair value of redeemable securities is measured at the
redemption amount that is payable (in cash and securities
representing each investor`s equal, undivided and vested
interest in the assets as a whole, subject to liabilities,
as defined by the Portfolio`s Trust Deed) at the balance
sheet date if security holders exercised their right to sell
the securities back to the Portfolio.
1.16 Increase/decrease in net assets attributable to security
holders
Income not distributed is included in net assets
attributable to security holders.
1.17 Forthcoming requirements
Future amendments not early adopted in the 2008 annual
financial statements
The following standards, amendments to standards, and
interpretations, effective for the first time in the future
accounting period, and which are relevant to the Portfolio,
have not been adopted for the year ended 31 December 2008:
IAS 1 `Presentation of Financial Statements` (effective 1
January 2009)
The changes include a requirement to introduce a statement
of comprehensive income. There will be some limited
presentational changes as a result of the introduction of
this standard but no changes in the measurement and
recognition.
IAS 32 `Financial Instruments: Presentation - Puttable
Financial Instruments and Obligations arising on
Liquidation`
The amendments to IAS 32 address this and require entities
to classify the following types of financial instruments as
equity, provided they have particular features and meet
specific conditions:
(i) Puttable financial instruments (for example, some shares
issued by co-operative entities);
and
(ii) Instruments, or components of instruments, that impose
on the entity an obligation to deliver to another party a
pro rata share of the net assets of the entity only on
liquidation (for example, some partnership interests and
some shares issued by limited life entities). Additional
disclosures are required for the instruments affected by the
amendments. The amendments will apply for annual periods
beginning on or after 1 January 2009, with earlier
application permitted.
31 March 2009
Sponsor
Java Capital (Proprietary) Limited
Trustee
ABSA Bank Limited
Date: 31/03/2009 17:11:58 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
